CTOs on the Move

Symmetry Surgical

www.symmetrysurgical.com

 
Symmetry Surgical is dedicated to developing high-quality surgical instruments that respond to clinicians` needs as they arise, making a real difference in the lives of patients.   Our broad portfolio also brings together the rich history and distinctive product lines of the recently acquired stainless steel and titanium surgical instruments of Codman, the surgical instruments of Specialty Surgical Instrumentation (SSI) and the electrosurgery instruments of Olsen Medical.   Offering one of the most comprehensive suites of surgical instruments in the industry, we continue to collaborate with clinicians, global medical device manufacturers and thousands of hospitals to provide solutions for today`s needs and tomorrow`s growth.   Headquartered ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Oklahoma Occupational Therapy Association (OOTA)

Oklahoma Occupational Therapy Association (OOTA) is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Baxter International

Baxter International Inc. through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Air Liquide Canada

Viveve

Viveve provides women low risk, high reward medical procedures that promote personal health and wellness.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.